Open | $5.940 |
Close | $6.630 |
Volume / Avg. | 110.865K / 40.360K |
Day Range | 5.590 - 7.000 |
52 Wk Range | 3.050 - 7.240 |
Market Cap | $201.797M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | % |
Days to Cover | 15.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of XBiotech (NASDAQ: XBIT) through any online brokerage.
Other companies in XBiotech’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Innate Pharma (NASDAQ:IPHA), Graphite Bio (NASDAQ:GRPH), Atossa Therapeutics (NASDAQ:ATOS) and FibroGen (NASDAQ:FGEN).
The latest price target for XBiotech (NASDAQ: XBIT) was reported by Piper Sandler on Tuesday, April 7, 2020. The analyst firm set a price target for 18.00 expecting XBIT to rise to within 12 months (a possible 171.49% upside). 0 analyst firms have reported ratings in the last year.
The stock price for XBiotech (NASDAQ: XBIT) is $6.63 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for XBiotech.
XBiotech’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for XBiotech.
XBiotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.